Lisata Therapeutics (LSTA) Institutional Ownership $2.69 +0.03 (+1.13%) Closing price 07/25/2025 04:00 PM EasternExtended Trading$2.68 -0.01 (-0.41%) As of 07/25/2025 07:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Lisata Therapeutics (NASDAQ:LSTA)CurrentInstitutional OwnershipPercentage8.94%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$112.42KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$159.37K Get LSTA Insider Trade Alerts Want to know when executives and insiders are buying or selling Lisata Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LSTA Institutional Buying and Selling by Quarter Lisata Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/7/2025BML Capital Management LLC216,853$510K0.4%-23.8%2.517% 2/17/2025Citadel Advisors LLC23,273$69K0.0%N/A0.277% 2/14/2025Dimensional Fund Advisors LP25,226$75K0.0%+45.5%0.301% 8/9/2024Dimensional Fund Advisors LP17,336$60K0.0%+48.2%0.209% 4/23/2024BML Capital Management LLC284,669$888K0.6%+5.5%3.426% 1/30/2024BML Capital Management LLC269,839$737K0.6%+10.7%3.315% 2/13/2023BML Capital Management LLC243,839$617K0.6%N/A3.102% (Data available from 1/1/2016 forward) LSTA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LSTA shares? During the previous two years, the following institutional investors and hedge funds held shares of Lisata Therapeutics shares: BML Capital Management LLC ($510K), and Dimensional Fund Advisors LP ($75K), Citadel Advisors LLC ($69K).Learn more on Lisata Therapeutics' institutional investors. What percentage of Lisata Therapeutics' stock is owned by institutional investors? 8.94% of Lisata Therapeutics' stock is owned by institutional investors. Learn more on LSTA's institutional investor holdings. Which institutional investors have been buying Lisata Therapeutics' stock? The following institutional investors have purchased Lisata Therapeutics' stock in the last 24 months: BML Capital Management LLC ($40.83K), Citadel Advisors LLC ($23.27K), and Dimensional Fund Advisors LP ($13.53K). How much institutional buying is happening at Lisata Therapeutics? Institutional investors have bought a total of 36,798 shares in the last 24 months. This purchase volume represents approximately $112.42K in transactions. Which of Lisata Therapeutics' major shareholders have been selling company stock? The following institutional investors have sold Lisata Therapeutics stock in the last 24 months: BML Capital Management LLC ($67.82K). How much institutional selling is happening at Lisata Therapeutics? Institutional investors have sold a total of 67,816 shares in the last 24 months. This volume of shares sold represents approximately $159.37K in transactions. Related Companies OKYO Pharma Institutional Ownership Elutia Institutional Ownership XBiotech Institutional Ownership Oramed Pharmaceuticals Institutional Ownership Entera Bio Institutional Ownership Pliant Therapeutics Institutional Ownership Vaxart Institutional Ownership Adagene Institutional Ownership Cabaletta Bio Institutional Ownership ESSA Pharma Institutional Ownership This page (NASDAQ:LSTA) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s $100 Trillion Land Rush Is OnWhat Is "The US: IPO"? You won't hear this on CNBC... but the government may soon open up hundreds of trill...Stansberry Research | SponsoredTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Goldco Precious Metals | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredElon Musk: “This will transform civilization as we know it.”Robots are no longer science fiction — they’re the next trillion-dollar megatrend. According to Forbes, by ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lisata Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lisata Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
